Ling-Zhijie Kong

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 6

Top Topics

Computed Tomography

Epstein Barr Virus

Metastatic Colorectal Cancer

Top Venues

Clinical case reports

OncoTargets and therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Yan Li, Ling-Zhijie Kong
A case of diffuse large B-cell lymphoma with decompensated alcohol-related liver cirrhosis treated successfully by chemoimmunotherapy. Clinical case reports 12 (4) (2024)
Yan Li, Ling-Zhijie Kong
A case of diffuse large B-cell lymphoma with decompensated alcohol-related liver cirrhosis treated successfully by chemoimmunotherapy. Clinical case reports 12 (4) (2024)
Ling-Zhijie Kong, Ying Zheng, Kaichun Li
Toripalimab and fruquintinib therapy for colorectal cancer after failed multiline chemotherapies: a case report. Immunotherapy 16 (2) (2023)
Ling-Zhijie Kong, Ying Zheng, Kaichun Li
Toripalimab and fruquintinib therapy for colorectal cancer after failed multiline chemotherapies: a case report. Immunotherapy 16 (2) (2023)
Ling-Zhijie Kong, Ying Zheng, Kaichun Li
Toripalimab and fruquintinib therapy for colorectal cancer after failed multiline chemotherapies: a case report. Immunotherapy (2023)
Ling-Zhijie Kong, Jing Li, Rui-Cang Wang, Lin Kang, Qiang Wei, Yan Li
Simultaneous Follicular Lymphoma and Myelofibrosis: Report of a Case with Review of the Literature. OncoTargets and therapy 14 (2021)